You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for amoxicillin; clarithromycin; vonoprazan fumarate and what is the scope of freedom to operate?

Amoxicillin; clarithromycin; vonoprazan fumarate is the generic ingredient in one branded drug marketed by Phathom and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Amoxicillin; clarithromycin; vonoprazan fumarate has one hundred and three patent family members in forty-three countries.

One supplier is listed for this compound.

Summary for AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE
International Patents:103
US Patents:2
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Clinical Trials: 2
DailyMed Link:AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE at DailyMed
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE
Generic Entry Date for AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE*:
Constraining patent/regulatory exclusivity:
GENERATING ANTIBIOTIC INCENTIVES NOW
Dosage:
CAPSULE, TABLET, TABLET;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The First Affiliated Hospital with Nanjing Medical UniversityPhase 4
Jining No.2 People's HospitalPhase 4
The Affiliated Hospital of Qingdao UniversityPhase 4

See all AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE clinical trials

US Patents and Regulatory Information for AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Phathom VOQUEZNA TRIPLE PAK amoxicillin; clarithromycin; vonoprazan fumarate CAPSULE, TABLET, TABLET;ORAL 215152-001 May 3, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Phathom VOQUEZNA TRIPLE PAK amoxicillin; clarithromycin; vonoprazan fumarate CAPSULE, TABLET, TABLET;ORAL 215152-001 May 3, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Phathom VOQUEZNA TRIPLE PAK amoxicillin; clarithromycin; vonoprazan fumarate CAPSULE, TABLET, TABLET;ORAL 215152-001 May 3, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Phathom VOQUEZNA TRIPLE PAK amoxicillin; clarithromycin; vonoprazan fumarate CAPSULE, TABLET, TABLET;ORAL 215152-001 May 3, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE

Country Patent Number Title Estimated Expiration
Dominican Republic P2011000033 COMPOSICION FARMACEUTICA ⤷  Sign Up
Ecuador SP11010855 COMPOSICIÓN FARMACÉUTICA ⤷  Sign Up
Chile 2013000224 Preparacion solida mejorada que comprende un ingrediente farmaceuticamente activo, un plastificante y un acido organico de cadena; metodo para estabilizar una preparacion solida (divisional sol 170-11) ⤷  Sign Up
Malaysia 169461 PHARMACEUTICAL COMPOSITION ⤷  Sign Up
Montenegro 00610 1 -HETEROCIKLILSULFONIL, 2 -AMINOMETIL, 5- (HETERO-) ARIL SUPSTITUISAN 1-H-PIROL DERIVATI KAO INHIBITORI LUČENJA KISELINE (1-HETEROCYCLYLSULFONYL, 2-AMINOMETHYL, 5- (HETERO-) ARYL SUBSTITUTED 1-H-PYRROLE DERIVATIVES AS ACID SECRETION INHIBITORS) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.